Publication: Pharmacotherapy of depression in Thailand: Country report 1999
Issued Date
2000-02-01
Resource Type
ISSN
00375675
Other identifier(s)
2-s2.0-0034090012
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Singapore Medical Journal. Vol.41, No.3 SUPPL. 1 (2000), 53-54
Suggested Citation
C. Sukying Pharmacotherapy of depression in Thailand: Country report 1999. Singapore Medical Journal. Vol.41, No.3 SUPPL. 1 (2000), 53-54. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/26286
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pharmacotherapy of depression in Thailand: Country report 1999
Author(s)
Other Contributor(s)
Abstract
Thailand has a population of approximately 61 million. The prevalence of mental disorders among the population in Bangkok was 21.3%, with approximately one-fifth being depressive disorders. A study on the patterns of psychotropic drug prescriptions by general practitioners indicated that only one-third of primary care attenders received any psychiatric treatments. Amitryptyline was the most commonly used antidepressants (96.7%). The National Drug Committee policy encourages general practitioners to use only drugs available from the National List of Essential Drugs. The economic crisis in the region has also worsened the situation. The Department of Mental Health has recently developed the practice guideline on the care of patients with mood disorders.